Cargando…
Overexpression of CCDC69 activates p14(ARF)/MDM2/p53 pathway and confers cisplatin sensitivity
OBJECTIVES: The aim of the study is to explore the relationship between CCDC69 expression and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism. METHODS: One hundred thirty five ovarian cancer patients with intact chemo-response information from The Cancer Genome At...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334460/ https://www.ncbi.nlm.nih.gov/pubmed/30651135 http://dx.doi.org/10.1186/s13048-019-0479-3 |